Provided by Tiger Fintech (Singapore) Pte. Ltd.

Editas Medicine

3.15
-0.1100-3.37%
Post-market: 3.190.0400+1.27%19:44 EDT
Volume:1.28M
Turnover:4.04M
Market Cap:263.70M
PE:-1.04
High:3.28
Open:3.28
Low:3.10
Close:3.26
Loading ...
Feb 24, 2022

Major Issues Report

8-K - Current report
Feb 14, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 09, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2022

Major Issues Report

8-K - Current report
Feb 04, 2022

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Nov 15, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Nov 10, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 28, 2021

Statement Of Changes In Beneficial Ownership

3 - Initial statement of beneficial ownership of securities
Oct 28, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 20, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Oct 04, 2021

Statement Of Changes In Beneficial Ownership

4 - Statement of changes in beneficial ownership of securities
Sep 29, 2021

Major Issues Report

8-K - Current report
Sep 08, 2021

Major Issues Report

8-K - Current report
Aug 05, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 04, 2021

Major Issues Report

8-K - Current report
Jun 08, 2021

Major Issues Report

8-K - Current report
May 14, 2021

Major Issues Report

8-K - Current report
May 06, 2021

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
May 05, 2021

Major Issues Report

8-K - Current report